과제정보
We thank Sarah Kwon of the ultrasound division of Canon Medical Systems Korea Co. Ltd. for her assistance with ultrasound physics.
참고문헌
- Folkman J. Angiogenesis and breast cancer. J Clin Oncol 1994;12:441-443 https://doi.org/10.1200/JCO.1994.12.3.441
- Uzzan B, Nicolas P, Cucherat M, Perret GY. Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis. Cancer Res 2004;64:2941-2955 https://doi.org/10.1158/0008-5472.CAN-03-1957
- Schroeder RJ, Bostanjoglo M, Rademaker J, Maeurer J, Felix R. Role of power Doppler techniques and ultrasound contrast enhancement in the differential diagnosis of focal breast lesions. Eur Radiol 2003;13:68-79 https://doi.org/10.1007/s00330-002-1413-3
- Park AY, Seo BK. Up-to-date Doppler techniques for breast tumor vascularity: superb microvascular imaging and contrast-enhanced ultrasound. Ultrasonography 2018;37:98-106 https://doi.org/10.14366/usg.17043
- Yoo J, Je BK, Choo JY. Ultrasonographic demonstration of the tissue microvasculature in children: microvascular ultrasonography versus conventional color Doppler ultrasonography. Korean J Radiol 2020;21:146-158 https://doi.org/10.3348/kjr.2019.0500
- Seeing the unseen with superb micro-vascular imaging (SMI). Global.medical.canon Web site. https://global.medical.canon/products/ultrasound/aplio_platinum_imaging03.html. Accessed November 9, 2020
- Drudi FM, Cantisani V, Gnecchi M, Malpassini F, Di Leo N, de Felice C. Contrast-enhanced ultrasound examination of the breast: a literature review. Ultraschall Med 2012;33:E1-E7 https://doi.org/10.1055/s-0031-1299408
- Park AY, Seo BK, Woo OH, Jung KS, Cho KR, Park EK, et al. The utility of ultrasound superb microvascular imaging for evaluation of breast tumour vascularity: comparison with colour and power Doppler imaging regarding diagnostic performance. Clin Radiol 2018;73:304-311 https://doi.org/10.1016/j.crad.2017.10.006
- Ma Y, Li G, Li J, Ren WD. The diagnostic value of superb microvascular imaging (SMI) in detecting blood flow signals of breast lesions: a preliminary study comparing SMI to color Doppler flow imaging. Medicine (Baltimore) 2015;94:e1502
- Zhan J, Diao XH, Jin JM, Chen L, Chen Y. Superb microvascular imaging-a new vascular detecting ultrasonographic technique for avascular breast masses: a preliminary study. Eur J Radiol 2016;85:915-921 https://doi.org/10.1016/j.ejrad.2015.12.011
- Yongfeng Z, Ping Z, Wengang L, Yang S, Shuangming T. Application of a novel microvascular imaging technique in breast lesion evaluation. Ultrasound Med Biol 2016;42:2097-2105 https://doi.org/10.1016/j.ultrasmedbio.2016.05.010
- Park AY, Kwon M, Woo OH, Cho KR, Park EK, Cha SH, et al. A prospective study on the value of ultrasound microflow assessment to distinguish malignant from benign solid breast masses: association between ultrasound parameters and histologic microvessel densities. Korean J Radiol 2019;20:759-772 https://doi.org/10.3348/kjr.2018.0515
- Zhang XY, Zhang L, Li N, Zhu QL, Li JC, Sun Q, et al. Vascular index measured by smart 3-D superb microvascular imaging can help to differentiate malignant and benign breast lesion. Cancer Manag Res 2019;11:5481-5487 https://doi.org/10.2147/CMAR.S203376
- Chae EY, Yoon GY, Cha JH, Shin HJ, Choi WJ, Kim HH. Added value of the vascular index on superb microvascular imaging for the evaluation of breast masses: comparison with grayscale ultrasound. J Ultrasound Med 2020 Aug [Epub]. https://doi.org/10.1002/jum.15441
- Kim S, Lee HJ, Ko KH, Park AY, Koh J, Jung HK. New Doppler imaging technique for assessing angiogenesis in breast tumors: correlation with immunohistochemically analyzed microvessels density. Acta Radiol 2018;59:1414-1421 https://doi.org/10.1177/0284185118769690
- Kim ES, Seo BK, Park EK, Woo OH, Jung K, Cho KR, et al. Significance of microvascular evaluation of ductal lesions on breast ultrasonography: influence on diagnostic performance. Clin Imaging 2018;51:252-259 https://doi.org/10.1016/j.clinimag.2018.05.024
- Bakdik S, Arslan S, Oncu F, Durmaz MS, Altunkeser A, Eryilmaz MA, et al. Effectiveness of superb microvascular imaging for the differentiation of intraductal breast lesions. Med Ultrason 2018;20:306-312 https://doi.org/10.11152/mu-1433
- Du J, Wang L, Wan CF, Hua J, Fang H, Chen J, et al. Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging. Eur J Radiol 2012;81:3890-3899 https://doi.org/10.1016/j.ejrad.2012.09.004
- Miyamoto Y, Ito T, Takada E, Omoto K, Hirai T, Moriyasu F. Efficacy of sonazoid (perflubutane) for contrast-enhanced ultrasound in the differentiation of focal breast lesions: phase 3 multicenter clinical trial. AJR Am J Roentgenol 2014;202:W400-W407 https://doi.org/10.2214/AJR.12.10518
- Wan C, Du J, Fang H, Li F, Wang L. Evaluation of breast lesions by contrast enhanced ultrasound: qualitative and quantitative analysis. Eur J Radiol 2012;81:e444-e450 https://doi.org/10.1016/j.ejrad.2011.03.094
- Zhao YX, Liu S, Hu YB, Ge YY, Lv DM. Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: a retrospective study. Onco Targets Ther 2017;10:1123-1129 https://doi.org/10.2147/OTT.S124134
- Hu Q, Wang XY, Zhu SY, Kang LK, Xiao YJ, Zheng HY. Meta-analysis of contrast-enhanced ultrasound for the differentiation of benign and malignant breast lesions. Acta Radiol 2015;56:25-33 https://doi.org/10.1177/0284185113517115
- Li Q, Hu M, Chen Z, Li C, Zhang X, Song Y, et al. Meta-analysis: contrast-enhanced ultrasound versus conventional ultrasound for differentiation of benign and malignant breast lesions. Ultrasound Med Biol 2018;44:919-929 https://doi.org/10.1016/j.ultrasmedbio.2018.01.022
- Ma Y, Li J, Ren W, Deng L. Correlation between superb microvascular imaging and pathological microvessel density in breast tumors. Xiangya Med 2016;1:30
- Wan CF, Du J, Fang H, Li FH, Zhu JS, Liu Q. Enhancement patterns and parameters of breast cancers at contrast-enhanced US: correlation with prognostic factors. Radiology 2012;262:450-459 https://doi.org/10.1148/radiol.11110789
- Mori N, Mugikura S, Takahashi S, Ito K, Takasawa C, Li L, et al. Quantitative analysis of contrast-enhanced ultrasound imaging in invasive breast cancer: a novel technique to obtain histopathologic information of microvessel density. Ultrasound Med Biol 2017;43:607-614 https://doi.org/10.1016/j.ultrasmedbio.2016.11.009
- Jung HK, Park AY, Ko KH, Koh J. Comparison of the diagnostic performance of power Doppler ultrasound and a new microvascular Doppler ultrasound technique (AngioPLUS) for differentiating benign and malignant breast masses. J Ultrasound Med 2018;37:2689-2698 https://doi.org/10.1002/jum.14602
- Bae JS, Lee JM, Jeon SK, Jang S. Comparison of MicroFlow Imaging with color and power Doppler imaging for detecting and characterizing blood flow signals in hepatocellular carcinoma. Ultrasonography 2020;39:85-93 https://doi.org/10.14366/usg.19033
- Park AY, Seo BK, Cha SH, Yeom SK, Lee SW, Chung HH. An innovative ultrasound technique for evaluation of tumor vascularity in breast cancers: superb micro-vascular imaging. J Breast Cancer 2016;19:210-213 https://doi.org/10.4048/jbc.2016.19.2.210
- Zhong L, Wang C. Diagnostic accuracy of ultrasound superb microvascular imaging for breast tumor: a meta-analysis. Med Ultrason 2020;22:313-318 https://doi.org/10.11152/mu-2460
- Tek C, Oztekin PS, Celepli P, Ucar F, Kos,ar PN. Using the superb microvascular imaging method in the distinction of intraductal papilloma and duct ectasia with secretion. J Ultrasound Med 2020 Jul [Epub]. https://doi.org/10.1002/jum.15396
- Son MJ, Kim S, Jung HK, Ko KH, Koh JE, Park AY. Can ultrasonographic vascular and elastographic features of invasive ductal breast carcinoma predict histologic aggressiveness? Acad Radiol 2020;27:487-496 https://doi.org/10.1016/j.acra.2019.06.009
- Chung YE, Kim KW. Contrast-enhanced ultrasonography: advance and current status in abdominal imaging. Ultrasonography 2015;34:3-18 https://doi.org/10.14366/usg.14034
- Kedar RP, Cosgrove D, McCready VR, Bamber JC, Carter ER. Microbubble contrast agent for color Doppler US: effect on breast masses. Work in progress. Radiology 1996;198:679-686 https://doi.org/10.1148/radiology.198.3.8628854
- Xiao XY, Chen X, Guan XF, Wu H, Qin W, Luo BM. Superb microvascular imaging in diagnosis of breast lesions: a comparative study with contrast-enhanced ultrasonographic microvascular imaging. Br J Radiol 2016;89:20160546
- Pinker K, Chin J, Melsaether AN, Morris EA, Moy L. Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment. Radiology 2018;287:732-747 https://doi.org/10.1148/radiol.2018172171
- Park AY, Han MR, Park KH, Kim JS, Son GS, Lee HY, et al. Radiogenomic analysis of breast cancer by using B-mode and vascular US and RNA sequencing. Radiology 2020;295:24-34 https://doi.org/10.1148/radiol.2020191368
- Talukder AH, Meng Q, Kumar R. CRIPak, a novel endogenous Pak1 inhibitor. Oncogene 2006;25:1311-1319 https://doi.org/10.1038/sj.onc.1209172
- Yin S, Xu L, Bonfil RD, Banerjee S, Sarkar FH, Sethi S, et al. Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancer. Mol Cancer Ther 2013;12:491-498 https://doi.org/10.1158/1535-7163.MCT-12-1090
- Dai DN, Li Y, Chen B, Du Y, Li SB, Lu SX, et al. Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis. J Mol Med (Berl) 2017;95:873-886 https://doi.org/10.1007/s00109-017-1537-1
- Salmans ML, Zhao F, Andersen B. The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker. Breast Cancer Res 2013;15:204
- Wang X, Zhu J. Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53. Thorac Cancer 2018;9:676-683 https://doi.org/10.1111/1759-7714.12607
- Nayak SR, Harrington E, Boone D, Hartmaier R, Chen J, Pathiraja TN, et al. A role for histone H2B variants in endocrine-resistant breast cancer. Horm Cancer 2015;6:214-224 https://doi.org/10.1007/s12672-015-0230-5
- He J, Mai J, Li Y, Chen L, Xu H, Zhu X, et al. miR-597 inhibits breast cancer cell proliferation, migration and invasion through FOSL2. Oncol Rep 2017;37:2672-2678 https://doi.org/10.3892/or.2017.5558
- Cunningham F, Achuthan P, Akanni W, Allen J, Amode MR, Armean IM, et al. Ensembl 2019. Nucleic Acids Res 2019;47:D745-D751 https://doi.org/10.1093/nar/gky1113